Shares of Ra Medical Systems Inc. (NYSE American:RMED) traded today at $2.85, breaking its 52-week low. This new low was reached on below average trading volume as 815,000 shares traded hands, while the average 30-day volume is approximately 3.4 million shares.
In the past 52 weeks, Ra Medical Systems Inc. share prices are bracketed by a current low of $2.85 and a high of $20.77 and is now at $3.01.
Potential upside of 95.7% exists for Ra Medical Systems Inc., based on a current level of $3.01 and analysts' average consensus price target of $5.89.
Ra Medical Systems Inc is a commercial-stage medical device company leveraging its laser-based platform for use in the treatment of vascular and dermatological immune-mediated inflammatory diseases. Its products restore blood-flow in arteries and clearing chronic skin conditions. The firm's products include DABRA and Pharos. DABRA System is used as a tool in the treatment of peripheral artery disease, or PAD, a form of peripheral vascular disease, which commonly occurs in the legs. Pharos is designed for use in the treatment of inflammatory skin conditions and as a tool in the treatment of psoriasis, vitiligo, atopic dermatitis, and leukoderma. It operates in two segments, the Vascular segment and the Dermatology segment, of which key revenue is derived from the Dermatology segment.
Receive IBN Spotlights - "Bite Size" Small, Mid and Large-Cap Technical Indicator Alerts
To stay connected with our complimentary IBN Spotlights, please visit https://IBN.fm/connected
About InvestorBrandNetwork (IBN)
InvestorBrandNetwork (IBN) consists of 50+ trusted financial brands introduced to the investment public over the course of 15+ years. Through these brands, IBN provides (1) access to our Investor Press Release Wire Solutions via InvestorWire (IW) to reach all target markets, industries and demographics in the most effective manner possible; (2) article and editorial syndication to 5,000+ news outlets; (3) enhanced press release solutions via IW to ensure maximum impact; (4) full-scale distribution to an enormous social media audience that includes millions of followers; and (5) a full array of corporate communications solutions focused on the IBN Podcast Series. With a proven track record serving 500+ client partners, IBN is the key to a more effective market communication campaign.
For more information, please visit https://www.InvestorBrandNetwork.com
Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://IBN.fm/Disclaimer